Kestra Advisory Services
IMVT icon

Kestra Advisory Services’s Immunovant IMVT Stock Holding History

Kestra Advisory Services’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$583K Buy
17,273
+751
+5% +$29.6K ﹤0.01% 2368
2026
Q2 		$637K Buy
16,522
+2,607
+19% +$79.4K ﹤0.01% 2150
2026
Q1 		$346K Buy
13,915
+4,936
+55% +$128K ﹤0.01% 2505
2025
Q4 		$228K Buy
+8,979
New +$200K ﹤0.01% 2771

Other funds holding IMVT

Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Arizona State Retirement System
Arizona State Retirement System Phoenix, Arizona $20.3B AUM 36.55% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Kestra Advisory Services's IMVT Position: Q3 2026 in Review

Kestra Advisory Services increased its Immunovant (IMVT) stake by 4.5% in Q3 2026, buying an estimated $29.6K and bringing the position to 17,273 shares worth $583K. The position accounts for ﹤0.01% of the portfolio, ranked #2368.

Kestra Advisory Services first reported a position in IMVT in Q4 2025 and has held it in 4 quarters since. The position peaked at $637K in Q2 2026. 46 funds tracked by Wall St. Rank hold IMVT as of Q3 2026.

  • Kestra Advisory Services held 17,273 shares of Immunovant worth $583K as of Q3 2026.
  • Kestra Advisory Services bought 751 Immunovant shares in Q3 2026, an estimated $29.6K.
  • Immunovant made up ﹤0.01% of Kestra Advisory Services's portfolio in Q3 2026, its #2368 holding.
  • Kestra Advisory Services first reported a position in Immunovant in Q4 2025 and has held it in 4 quarters since.
  • Kestra Advisory Services's Immunovant position peaked at $637K in Q2 2026.
  • 46 funds tracked by Wall St. Rank held Immunovant as of Q3 2026.

Based on Kestra Advisory Services's 13F filing for Q3 2026, filed 2 Nov 2026.